Increased connexin 43 expression as a potential mediator of the neuroprotective activity of the corticotropin-releasing hormone

Molecular Endocrinology

Volumn 23, Issue 9, 2009, Pages 1479-1493

  Hanstein, Regina ^a,b   Trotter, Jacqueline ^a   Behl, Christian ^a   Clement, Angela B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CARBENOXOLONE; CASPASE 3; CONNEXIN 43; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C FOS; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; UROCORTIN; UROCORTIN III;

ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL COMMUNICATION; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GAP JUNCTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MEDIATOR; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE CULTURE; UPREGULATION;

ANIMALS; BRAIN; CELL LINE, TUMOR; CONNEXIN 43; CORTICOTROPIN-RELEASING HORMONE; GAP JUNCTIONS; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 69449101121     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0022     Document Type: Article

References (85)

1. Vale W, Spiess J, Rivier C, Rivier J 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213:1394-1397 (Pubitemid 12243637)
2. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971 (Pubitemid 23306432)
3. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, De Souza EB 1996 Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137:72-77 (Pubitemid 26004975)
4. Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB 1996 Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein - implications for the treatment of CNS disorders [Review]. Mol Psychiatry 1:265-277 (Pubitemid 126441312)
5. Steckler T, Holsboer F 1999 Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46:1480-1508
6. Ock J, Lee H, Kim S, Lee WH, Choi DK, Park EJ, Kim SH, Kim IK, Suk K 2006 Induction of microglial apoptosis by corticotropin-releasing hormone. J Neurochem 98:962-972 (Pubitemid 44051295)
7. Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP 2003 Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab 23:1151-1159 (Pubitemid 37229518)
8. Grammatopoulos DK, Chrousos GP 2002 Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436-444
9. Wang H, Wang Y, Qu Y, Qi R, Lu D, Li C, Yan L 2001 The cAMP-mediated protein kinase signal transduction pathway is involved in the pyrogenic effect of CRH in rats. Chin Med J (Engl) 114:1064-1067
10. Dermitzaki E, Tsatsanis C, Charalampopoulos I, Androulidaki A, Alexaki VI, Castanas E, Gravanis A, Margioris AN 2005 Corticotropin- releasing hormone activates protein kinase C in an isoenzyme- specific manner. Biochem Biophys Res Commun 327:828-836 (Pubitemid 40092823)
11. Dermitzaki E, Tsatsanis C, Gravanis A, Margioris AN 2002 Corticotropin- releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase. J Biol Chem 277:12280-12287 (Pubitemid 34952797)
12. Vila G, Papazoglou M, Stalla J, Theodoropoulou M, Stalla GK, Holsboer F, Paez-Pereda M 2005 Sonic hedgehog regulates CRH signal transduction in the adult pituitary. FASEB J 19:281-283 (Pubitemid 40189282)
13. Lyons MK, Anderson RE, Meyer FB 1991 Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury. Brain Res 545:339-342
14. Strijbos PJ, Relton JK, Rothwell NJ 1994 Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Brain Res 656:405-408 (Pubitemid 24277126)
15. Fox MW, Anderson RE, Meyer FB 1993 Neuroprotection by corticotropin releasing factor during hypoxia in rat brain. Stroke 24: 1072-1075; discussion 1075-1076
16. Charron C, Fréchette S, Proulx G, Plamondon H 2008 In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors. Behav Brain Res 188:125-135
17. Elliott-Hunt CR, Kazlauskaite J, Wilde GJ, Grammatopoulos DK, Hillhouse EW 2002 Potential signalling pathways underlying corticotrophin- releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J Neurochem 80:416-425 (Pubitemid 36383025)
18. Hanstein R, Lu A, Wurst W, Holsboer F, Deussing JM, Clement AB, Behl C 2008 Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress. Neuroscience 156:712-721
19. Abuirmeileh A, Harkavyi A, Kingsbury A, Lever R, Whitton PS 2009 The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors. Eur J Pharmacol 604:45-50
20. Lezoualc'h F, Engert S, Berning B, Behl C 2000 Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid β precursor protein and with the suppression of nuclear factor-κB. Mol Endocrinol 14:147-159
21. Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP, Mattson MP 2001 Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol Dis 8:492-503 (Pubitemid 32566139)
22. Bayatti N, Zschocke J, Behl C 2003 Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons. Endocrinology 144:4051-4060 (Pubitemid 37088760)
23. Facci L, Stevens DA, Pangallo M, Franceschini D, Skaper SD, Strijbos PJ 2003 Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. Neuropharmacology 45:623-636 (Pubitemid 36980819)
24. De Souza EB, Whitehouse PJ, Price DL, Vale WW 1987 Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Ann NY Acad Sci 512:237-247
25. Bayatti N, Behl C 2005 The neuroprotective actions of corticotropin releasing hormone. Ageing Res Rev 4:258-270 (Pubitemid 41111981)
26. Bayatti N, Hermann H, Lutz B, Behl C 2005 Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system. Endocrinology 146:1205-1213 (Pubitemid 40289309)
27. Söhl G, Maxeiner S, Willecke K 2005 Expression and functions of neuronal gap junctions. Nat Rev Neurosci 6:191-200 (Pubitemid 40342414)
28. Nagy JI, Rash JE 2000 Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 32:29-44 (Pubitemid 30177308)
29. Blanc EM, Bruce-Keller AJ, Mattson MP 1998 Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of Ca2+ homeostasis and cell death. J Neurochem 70:958-970
30. Kirchhoff F, Dringen R, Giaume C 2001 Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur Arch Psychiatry Clin Neurosci 251:159-169 (Pubitemid 32963493)
31. Zündorf G, Kahlert S, Reiser G 2007 Gap-junction blocker carbenoxolone differentially enhances NMDA-induced cell death in hippocampal neurons and astrocytes in co-culture. J Neurochem 102:508-521 (Pubitemid 47000594)
32. Besancon E, Guo S, Lok J, Tymianski M, Lo EH 2008 Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 29:268-275
33. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA 1995 Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43. J Membr Biol 148:243-253 (Pubitemid 26017800)
34. Darrow BJ, Fast VG, Kléber AG, Beyer EC, Saffitz JE 1996 Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. Circ Res 79:174-183
35. Ek-Vitorin JF, King TJ, Heyman NS, Lampe PD, Burt JM 2006 Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation. Circ Res 98:1498-1505
36. Rivedal E, Leithe E 2005 Connexin43 synthesis, phosphorylation, and degradation in regulation of transient inhibition of gap junction intercellular communication by the phorbol ester TPA in rat liver epithelial cells. Exp Cell Res 302:143-152 (Pubitemid 39550457)
37. Hogg JE, Myers J, Hutson PH 1996 The human neuroblastoma cell line, IMR-32, expresses functional corticotropin-releasing factor receptors. Eur J Pharmacol 312:257-261 (Pubitemid 26325688)
38. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin- releasing factor. Nature 378:287-292
39. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW 2001 Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575 (Pubitemid 32567989)
40. Musil LS, Goodenough DA 1991 Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 115:1357-1374
41. Paul DL 1986 Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol 103:123-134 (Pubitemid 16066998)
42. Segretain D, Falk MM 2004 Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim Biophys Acta 1662:3-21 (Pubitemid 38366510)
43. Polontchouk L, Ebelt B, Jackels M, Dhein S 2002 Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 16:87-89
44. McEvoy AN, Bresnihan B, Fitzgerald O, Murphy EP 2002 Corticotropin- releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway. Ann NY Acad Sci 966:119-130 (Pubitemid 34729168)
45. Graziani G, Tentori L, Muzi A, Vergati M, Tringali G, Pozzoli G, Navarra P 2007 Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Mol Cell Endocrinol 264:44-49 (Pubitemid 46097300)
46. Rossant CJ, Pinnock RD, Hughes J, Hall MD, McNulty S 1999 Corticotropin-releasing factor type 1 and type 2α receptors regulate phosphorylation of calcium/cyclic adenosine 3′,5′-monophosphate response element-binding protein and activation of p42/p44 mitogen- activated protein kinase. Endocrinology 140:1525-1536 (Pubitemid 29149218)
47. Boutillier AL, Sassone-Corsi P, Loeffler JP 1991 The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Mol Endocrinol 5:1301-1310
48. Becquet D, Guillaumond F, Bosler O, Françcois-Bellan AM 2001 Long-term variations of AP-1 composition after CRH stimulation: consequence on POMC gene regulation. Mol Cell Endocrinol 175:93-100 (Pubitemid 32377173)
49. Autelitano DJ, Cohen DR 1996 CRF stimulates expression of multiple fos and jun related genes in the AtT-20 corticotroph cell. Mol Cell Endocrinol 119:25-35
50. Mitchell JA, Lye SJ 2005 Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. Endocrinology 146:2048-2054
51. Yuan J, Horvitz HR 2004 A first insight into the molecular mechanisms of apoptosis. Cell 116:S53-S56, 1 p following S59
52. Hengartner MO 2000 The biochemistry of apoptosis. Nature 407:770-776
53. Goldberg GS, Lampe PD, Nicholson BJ 1999 Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat Cell Biol 1:457-459
54. Laird DW, Puranam KL, Revel JP 1991 Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 273:67-72
55. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N 2005 Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res 97:655-662 (Pubitemid 41416334)
56. Le AC, Musil LS 2001 A novel role for FGF and extracellular signal-regulated kinase in gap junction-mediated intercellular communication in the lens. J Cell Biol 154:197-216
57. Shaulian E, Karin M 2002 AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136 (Pubitemid 34521026)
58. Hai T, Curran T 1991 Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720-3724 (Pubitemid 21916695)
59. Geimonen E, Jiang W, Ali M, Fishman GI, Garfield RE, Andersen J 1996 Activation of protein kinase C in human uterine smooth muscle induces connexin-43 gene transcription through an AP-1 site in the promoter sequence. J Biol Chem 271:23667-23674 (Pubitemid 26327331)
60. Echetebu CO, Ali M, Izban MG, MacKay L, Garfield RE 1999 Localization of regulatory protein binding sites in the proximal region of human myometrial connexin 43 gene. Mol Hum Reprod 5:757-766 (Pubitemid 29366874)
61. Wu X, Shen H, Yu L, Peng M, Lai WS, Ding YL 2007 Corticotropin- releasing hormone activates connexin 43 via activator protein-1 transcription factor in human myometrial smooth muscle cells. Am J Physiol Endocrinol Metab 293:E1789-E1794 (Pubitemid 350255133)
62. Pedersen WA, Wan R, Zhang P, Mattson MP 2002 Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J Neurosci 22:404-412 (Pubitemid 34049078)
63. Ozog MA, Siushansian R, Naus CC 2002 Blocked gap junctional coupling increases glutamate-induced neurotoxicity in neuron-astrocyte co-cultures. J Neuropathol Exp Neurol 61:132-141 (Pubitemid 34127097)
64. Giardina SF, Mikami M, Goubaeva F, Yang J 2007 Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis. Biochem Biophys Res Commun 362:747-752 (Pubitemid 47368157)
65. Hutnik CM, Pocrnich CE, Liu H, Laird DW, Shao Q 2008 The protective effect of functional connexin43 channels on a human epithelial cell line exposed to oxidative stress. Invest Ophthalmol Vis Sci 49:800-806
66. Perez Velazquez JL, Frantseva MV, Naus CC 2003 Gap junctions and neuronal injury: protectants or executioners? Neuroscientist 9:5-9
67. Rouach N, Koulakoff A, Giaume C 2004 Neurons set the tone of gap junctional communication in astrocytic networks. Neurochem Int 45:265-272 (Pubitemid 38625618)
68. Budd SL, Lipton SA 1998 Calcium tsunamis: do astrocytes transmit cell death messages via gap junctions during ischemia? Nat Neurosci 1:431-432
69. Cotrina ML, Kang J, Lin JH, Bueno E, Hansen TW, He L, Liu Y, Nedergaard M 1998 Astrocytic gap junctions remain open during ischemic conditions. J Neurosci 18:2520-2537 (Pubitemid 28141800)
70. Ruiz-Meana M, Garcia-Dorado D, Lane S, Pina P, Inserte J, Mirabet M, Soler-Soler J 2001 Persistence of gap junction communication during myocardial ischemia. Am J Physiol Heart Circ Physiol 280:H2563-H2571 (Pubitemid 32553296)
71. Nakase T, Söhl G, Theis M, Willecke K, Naus CC 2004 Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am J Pathol 164:2067-2075 (Pubitemid 38669354)
72. Tian JB, Bishop GA 2003 Frequency-dependent expression of corticotropin releasing factor in the rat's cerebellum. Neuroscience 121:363-377 (Pubitemid 37176924)
73. Même W, Calvo CF, Froger N, Ezan P, Amigou E, Koulakoff A, Giaume C 2006 Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by β-amyloid. FASEB J 20:494-496 (Pubitemid 46671227)
74. Wang MJ, Lin SZ, Kuo JS, Huang HY, Tzeng SF, Liao CH, Chen DC, Chen WF 2007 Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J Immunol 179:6204-6214
75. Giepmans BN, Verlaan I, Moolenaar WH 2001 Connexin-43 interactions with ZO-1 and α- and β-tubulin. Cell Commun Adhes 8:219-223
76. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, Spray DC 2007 The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 94:245-264 (Pubitemid 46782981)
77. Trotter J, Bitter-Suermann D, Schachner M 1989 Differentiation-regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin. J Neurosci Res 22:369-383 (Pubitemid 19145619)
78. Pfaffl MW, Horgan GW, Dempfle L 2002 Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36
79. Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW 2003 Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J Biol Chem 278: 30005-30014 (Pubitemid 36962390)
80. Lin D, Takemoto DJ 2005 Oxidative activation of protein kinase Cγ through the C1 domain: effects on gap junctions. J Biol Chem 280:13682-13693 (Pubitemid 40517263)
81. Behl C, Davis JB, Lesley R, Schubert D 1994 Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827 (Pubitemid 24187680)
82. Vornov JJ, Park J, Thomas AG 1998 Regional vulnerability to endogenous and exogenous oxidative stress in organotypic hippocampal culture. Exp Neurol 149:109-122 (Pubitemid 28091020)
83. Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD, Neve R, Ratan RR 2003 Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 23:3597-3606 (Pubitemid 36958467)
84. Buchser WJ, Pardinas JR, Shi Y, Bixby JL, Lemmon VP 2006 96- well electroporation method for transfection of mammalian central neurons. Biotechniques 41:619-624 (Pubitemid 46534874)
85. Witan H, Kern A, Koziollek-Drechsler I, Wade R, Behl C, Clement AM 2008 Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation. Hum Mol Genet 17:1373-1385 (Pubitemid 351627334)